Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Actipulse Neuroscience Inc. is currently managing 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 2 actions are being reviewed by 2 distinct examiners, indicating that each pending matter has a separate point of contact. However, both actions are concentrated within 1 distinct art unit. The busiest examiner for the portfolio is MARMOR II, CHARLES ALAN, who is responsible for 1 busiest examiner pending action. This examiner handles 1 of the company's 2 pending office actions.
The concentration of 2 pending actions in 1 art unit suggests a specific technical focus within the Medical Devices & Mechanical Engineering sector. While the company receives feedback from 2 distinct examiners, the shared art unit environment may lead to some consistency in the technical standards applied to the 2 pending office actions. Practitioners should coordinate strategies to address the specific requirements of this 1 art unit while managing the individual styles of the 2 examiners. This structure allows the company to test its claims against 2 different perspectives within a single technical classification. The success of the 2 pending office actions will depend on navigating the 1 art unit's specific examination culture. This concentrated approach within 1 art unit requires a unified technical argument across both pending matters.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARMOR II, CHARLES ALAN | 1 | 12.6% | +26.3% |
| TRAN, LARA LINH | 1 | 16.7% | +90.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009151 | ALZHEIMER'S DISEASE PREVENTION OR TREATMENT WITH LOW INTENSITY AND HIGH FREQUENCY MAGNETIC STIMULATION | TRAN, LARA LINH | 87d overdue |
| 18561535 | MAJOR DEPRESSIVE DISORDER OR PERSISTENT DEPRESSIVE DISORDER PREVENTION OR TREATMENT WITH LOW INTENSITY AND HIGH FREQUENCY MAGNETIC STIMULATION | MARMOR II, CHARLES ALAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009151 | ALZHEIMER'S DISEASE PREVENTION OR TREATMENT WITH LOW INTENSITY AND HIGH FREQUENCY MAGNETIC STIMULATION | TRAN, LARA LINH | 87d overdue |
| 18561535 | MAJOR DEPRESSIVE DISORDER OR PERSISTENT DEPRESSIVE DISORDER PREVENTION OR TREATMENT WITH LOW INTENSITY AND HIGH FREQUENCY MAGNETIC STIMULATION | MARMOR II, CHARLES ALAN | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18561535 | MAJOR DEPRESSIVE DISORDER OR PERSISTENT DEPRESSIVE DISORDER PREVENTION OR TREATMENT WITH LOW INTENSITY AND HIGH FREQUENCY MAGNETIC STIMULATION | MARMOR II, CHARLES ALAN | 3791 | §103 | Final Rejection | — | Pending | Nov 17, 2023 |
| 18009151 | ALZHEIMER'S DISEASE PREVENTION OR TREATMENT WITH LOW INTENSITY AND HIGH FREQUENCY MAGNETIC STIMULATION | TRAN, LARA LINH | 3791 | §102§103 | Final Rejection | 87d overdue | Pending | Dec 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialActipulse Neuroscience Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Charles Alan Marmor II has the most, with 1 of Actipulse Neuroscience Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
